Saturday, March 21, 2020 4:37:22 AM
The Company plans to advance Brilacidin oral rinse into Phase 3 development, subject to available financial resources. Positive results were also observed in a Phase 2 Proof-of-Concept trial treating patients locally with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Click to copy
RELATED TOPICS
apf-health
Virus Outbreak
Globe Newswire
GlobeNewswire: Medical
PRESS RELEASE: Paid content from Globe Newswire
Innovation Pharmaceuticals Brilacidin Received by U.S. Regional Biocontainment Laboratory; Testing Against Coronavirus (COVID-19)
Innovation Pharmaceuticals Inc.
March 9, 2020
https://apnews.com/Globe%20Newswire/e8b34337537c7ece88e56b5354afde58U.S. Regional Biocontainment Lab to Begin Testing of Brilacidin Against Coronavirus (COVID-19) Next Week
https://www.globenewswire.com/news-release/2020/03/10/1997971/0/en/U-S-Regional-Biocontainment-Lab-to-Begin-Testing-of-Brilacidin-Against-Coronavirus-COVID-19-Next-Week.html
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
